

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb40492</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Simonian</surname><given-names>Miganoosh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Haji Ghaffari</surname><given-names>Mozhan</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Salimi</surname><given-names>Ali</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mirzadegan</surname><given-names>Ebrahim</given-names></name></contrib><aff>Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sadeghi</surname><given-names>Niloufar</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ebrahimnezhad</surname><given-names>Nasim</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fazli</surname><given-names>Ghazaleh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fatemi</surname><given-names>Ramina</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Bayat </surname><given-names>Ali Ahmad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Milani</surname><given-names>Saeideh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Negahdari</surname><given-names>Babak</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rabbani</surname><given-names>Hodjattallah</given-names></name></contrib><aff>Immune and Gene Therapy Laboratory, CCK, Karolinska University Hospital Solna      , Stockholm, Sweden</aff><aff>Department of Antigen and Antibody Engineering, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>37</fpage>
      <lpage>45</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>9</month>
          <year>2021</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Sortilin has an important role in various malignances and can be used as a promising target to eradicate cancer cells.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In this study, the expression of sortilin in 4T1 and MDA-MB231 cell lines was evaluated by flow cytometry and immunocytochemistry. Apoptosis assay was also applied to evaluate apoptosis induction in 4T1 and MDA-MB231 cell lines. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Based on cell surface flow cytometry results, anti-sortilin (2D8-E3) mAb could recognize sortilin molecules in 79.2% and 90.3% of 4T1 and MDA-MB231 cell-lines, respectively. The immunocytochemistry staining results confirmed sortilin surface expression. Apoptosis assay indicated that anti-sortilin mAb could induce apoptosis in 4T1 and MDA-MB231 cell lines.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Our study revealed the important role of surface sortilin in breast carcinoma cell survival and its possible application as a therapeutic agent in cancer targeted therapies.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
